STOCK TITAN

Perrigo Company plc - PRGO STOCK NEWS

Welcome to our dedicated news page for Perrigo Company plc (Ticker: PRGO), a resource for investors and traders seeking the latest updates and insights on Perrigo Company plc.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Perrigo Company plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Perrigo Company plc's position in the market.

Rhea-AI Summary
Perrigo Company plc (NYSE: PRGO) announced that its President and CEO, Patrick Lockwood-Taylor, and CFO Eduardo Bezerra will participate in investor meetings at the Jefferies Consumer Conference on November 15th, 2023, and present at the Morgan Stanley Consumer & Retail Conference on December 6th, 2023. Interested parties can access the webcast on the Perrigo website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.95%
Tags
conferences
-
Rhea-AI Summary
Perrigo Company plc plans to issue its Q3 2023 financial results on November 7, 2023, and will host a conference call. The call will be available live via webcast or by phone. A taped replay of the call will also be available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
-
News
Rhea-AI Summary
Perrigo appoints Catherine Schmelter as EVP and President, Consumer Self-Care Americas and Global Portfolio Optimization. Schmelter to lead strategic direction, growth, and profitability of CSCA business and oversee global portfolio evolution process.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
none
Rhea-AI Summary
Perrigo Company announces participation in investor meetings and conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
conferences
-
Rhea-AI Summary
Perrigo Company plc (NYSE: PRGO) reported second quarter net sales of $1.2 billion, a 6.4% increase compared to the prior year quarter. The company achieved gross and operating margin expansion and delivered strong operating income and EPS growth. The reported gross margin was 35.9%, a 270 basis points improvement, and the adjusted gross margin was 38.7%, a 220 basis points improvement. Reported EPS was $0.06, compared to a loss of $(0.48) in the prior year quarter. Adjusted diluted EPS was $0.63, a 46.5% increase. Perrigo reaffirms its fiscal 2023 outlook with organic net sales growth of 3.0%-6.0% and total net sales growth of 7.0%-11.0%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.53%
Tags
-
News
Rhea-AI Summary
Perrigo Company plc announces a quarterly dividend of $0.273 per share payable on September 19, 2023, to shareholders of record on September 1, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
dividends
Rhea-AI Summary
Perrigo Company plans to release its Q2 2023 financial results on August 8 and will host a conference call. The President and CEO, Patrick Lockwood-Taylor, and CFO Eduardo Bezerra will present at the Canaccord Genuity 43rd Annual Growth Conference on August 9.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
-
Rhea-AI Summary
Perrigo Company plc (NYSE: PRGO) announced that the FDA approved Opill®, a progestin-only daily oral contraceptive, for over-the-counter use. Opill® is the first birth control pill available over the counter in the United States. This approval has the potential to transform women's access to contraception.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.21%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
conferences
Perrigo Company plc

NYSE:PRGO

PRGO Rankings

PRGO Stock Data

4.11B
134.68M
0.31%
99.54%
2.85%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Ireland
Dublin

About PRGO

perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).